MedTrace Logo

Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage

NCT04328051 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2020-03-31

No results posted yet for this study

Summary

This study consists in a double-blinded randomized controlled trial which objective is to assess the effect of the implant-abutment connection type -external hexagon, internal hexagon and conical connection- in the periimplant marginal bone loss in vertical side and the bacterial leakage 12 months after prosthesis placement.

Conditions

Interventions

OTHER

Dental Implant Placement

Antibiotic prophylaxis will be done. After rinsing with 0.12 % chlorhexidine, patients will receive local anaesthesia. A crestal incision will be done and a mucoperiostic flap will be raised. As the commercial specifies, progressive diameter drills will be used under constant sterile saline irrigation to prepare the implant site. Once finished the drilling sequence, one investigator will open the opaque envelope to know which type of implant, depending on the connection, has to be placed by the surgeon. Dental implant will be placed crestally and depending if it has primary stability or not, it will be leaded submerged or non-submerged. The flap will be repositioned and sutured without tension with 4/0 polyamide. Postoperative instructions and medication will be prescribed and explained.

Sponsors & Collaborators

  • University of Barcelona

    lead OTHER

Principal Investigators

  • Rui Figueiredo, DDS, MS, PhD · University of Barcelona

  • Eduard Valmaseda-Castellón, DDS, MS, PhD · University of Barcelona

  • Octavi Camps-Font, DDS, MS · University of Barcelona

  • Roxana Ghiorghiu, DDS, MS · University of Barcelona

  • Laura Rubianes-Porta, DDS, MS · University of Barcelona

  • Anna Piñol-Olea, DDS, MS · University of Barcelona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-13
Primary Completion
2021-06-13
Completion
2021-12-13

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04328051 on ClinicalTrials.gov